We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KANG
376
DELISTED
iKang Healthcare Group, Inc.
KANG
| $7.34M | 0.03% |
487,771
| – | – |
|
377
Chevron
CVX
$388B
| $7.28M | 0.03% |
64,925
-68,037
| -51% | -$7.73M |
|
|
BTU
378
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $6.7M | 0.02% |
57,672
-2,383
| -4% | -$355K |
|
379
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.32B
| $6.64M | 0.02% |
+240,134
| New | +$6.82M |
|
380
Commault Systems
CVLT
$5.89B
| $6.64M | 0.02% |
128,406
-184,382
| -59% | -$8.86M |
|
381
Corpay
CPAY
$24.2B
| $6.61M | 0.02% |
44,443
| – | – |
|
|
PLG
382
Platinum Group Metals
PLG
$164M
| $6.6M | 0.02% |
139,386
+26,913
| +24% | +$1.91M |
|
|
OREX
383
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $6.56M | 0.02% |
108,304
| – | – |
|
|
EXAS
384
DELISTED
Exact Sciences
EXAS
| $6.51M | 0.02% |
237,158
-87,643
| -27% | -$2.13M |
|
385
Colgate-Palmolive
CL
$72.6B
| $6.46M | 0.02% |
93,324
+33,863
| +57% | +$2.29M |
|
|
INFA
386
DELISTED
INFORMATICA CORP
INFA
| $5.93M | 0.02% |
155,471
-17,125
| -10% | -$615K |
|
387
Adtran
ADTN
$798M
| $5.85M | 0.02% |
268,174
-39,759
| -13% | -$815K |
|
388
Lear
LEA
$7.19B
| $5.79M | 0.02% |
59,078
-16,122
| -21% | -$1.48M |
|
389
Healthpeak Properties
DOC
$15.4B
| $5.76M | 0.02% |
143,713
+13,328
| +10% | +$529K |
|
390
Metallus
MTUS
$873M
| $5.66M | 0.02% |
152,722
-199,479
| -57% | -$7.37M |
|
391
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
| $5.61M | 0.02% |
+192,254
| New | +$5.59M |
|
392
Bloomin' Brands
BLMN
$680M
| $5.57M | 0.02% |
+225,030
| New | +$4.74M |
|
|
SVA
393
DELISTED
Sinovac Biotech, Ltd
SVA
| $5.57M | 0.02% |
1,065,301
+116,001
| +12% | +$591K |
|
394
Atmos Energy
ATO
$29.9B
| $5.56M | 0.02% |
99,795
-8,781
| -8% | -$462K |
|
|
PKY
395
DELISTED
Parkway, Inc.
PKY
| $5.45M | 0.02% |
296,519
-104,382
| -26% | -$1.99M |
|
|
BSFT
396
DELISTED
BroadSoft, Inc.
BSFT
| $5.37M | 0.02% |
184,960
-23,307
| -11% | -$589K |
|
397
lululemon athletica
LULU
$13B
| $5.28M | 0.02% |
+94,645
| New | +$4.32M |
|
398
Toronto Dominion Bank
TD
$198B
| $5.25M | 0.02% |
109,850
| – | – |
|
|
EVAR
399
DELISTED
Lombard Medical, Inc.
EVAR
| $5.12M | 0.02% |
786,997
-78,983
| -9% | -$518K |
|
400
iShares MSCI Australia ETF
EWA
$1.34B
| $5.08M | 0.02% |
229,096
+121,968
| +114% | +$2.9M |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.